Aspirin May Be Associated With Lower Mortality In Patients With Type 2 Diabetes And Heart Failure,

reports that “in a large study of older patients with type 2 diabetes and heart failure,” investigators “found those taking aspirin for primary prevention had a lower mortality, specifically all-cause mortality with or without HF hospitalization over 5-year follow-up, but were paradoxically more likely to have a nonfatal myocardial infarction (MI) or stroke.” Medscape adds, “Surprisingly, bleeding risks were similar in both groups.” The findings are to be presented at the American College of Cardiology 2018 Scientific Session. https://login.medscape.com/login/sso/getlogin?urlCache=aHR0cHM6Ly93d3cubWVkc2NhcGUuY29tL3ZpZXdhcnRpY2xlLzg5MzcxMQ==&ac=401